Regeneron and Sanofi Announce Sarilumab Therapy Improves Symptoms in Rheumatoid Arthritis patients
News, rheumatoid arthritis
Regeneron Pharmaceuticals and Sanofi, two leading biopharmaceutical companies focused on researching and developing innovative therapeutic solutions, recently announced that Sarilumab, a human IL-6 receptor antibody, when administered to rheumatoid arthritis (RA) patients ... Read more